When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Despite the recent selloff, shares of Revance Therapeutics are up 65% since I gave a very bullish recommendation 2 years ago.
In that time, we have have seen an equity raise, acquisition of sales rights for RHA fillers from Teoxane, a convertible note offering and of course the COVID-19 pandemic.
In this article, I will explain why Revance Therapeutics still presents a fantastic opportunity for long-term investors.